Aquestive Therapeutics (AQST) Gross Margin Growth (1y) (2018 - 2026)
Aquestive Therapeutics (AQST) Gross Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 164.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -378.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -397.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -173.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 156.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -92.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 88.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aquestive Therapeutics | 583.72 Mn | 583.72 Mn | 9.80 Mn | 1,653.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,653.00 |
| Mar 31, 2026 | 3,515.00 |
| Dec 31, 2025 | -8,934.00 |
| Sep 30, 2025 | 2,158.00 |
| Jun 30, 2025 | -758.00 |
| Mar 31, 2025 | -3,061.00 |
| Dec 31, 2024 | 10,802.00 |
| Sep 30, 2024 | -3,276.00 |
| Jun 30, 2024 | -676.00 |
| Mar 31, 2024 | 3,128.00 |
| Dec 31, 2023 | 815.00 |
| Sep 30, 2023 | 4,035.00 |
| Jun 30, 2023 | 6,553.00 |
| Mar 31, 2023 | -820.00 |
| Dec 31, 2022 | -1,928.00 |
| Sep 30, 2022 | -723.00 |
| Jun 30, 2022 | 15,778.00 |
| Mar 31, 2022 | 12.00 |
| Dec 31, 2021 | 447.00 |
| Sep 30, 2021 | 411.00 |